Analysts at RBC Capital Markets have reduced their price target for IBM (NYSE:IBM) from $361 to $330, while upholding an Outperform rating ahead of the company’s upcoming first-quarter earnings.
IBM Stock Trades Below Recent Highs
IBM shares currently trade at $251, marking a roughly 23% decline from the 52-week high of $324.90. Valuation metrics, including a price-to-earnings ratio of 21.97 and a PEG ratio of 0.3, position the stock as undervalued relative to long-term growth potential in IT services and hybrid cloud operations.
RBC anticipates IBM’s next quarterly results, due on April 22, will align with expectations. Analyst Matt Swanson highlighted positive overall performance despite software segment results falling short of forecasts, buoyed by strong growth in the Red Hat cloud division.
Broader Analyst Adjustments
RBC’s revision reflects alignment with industry multiples amid expansions in infrastructure, AI-driven transactions, and software sales. Other firms have made similar moves:
- Oppenheimer cut its target from $380 to $320, maintaining Outperform, citing IBM’s significant multiple discount compared to peers.
- Bernstein SocGen Group lowered from $330 to $280 with a Market Perform rating, expressing caution on multibagger potential over five years.
- BofA Securities adjusted from $340 to $300, factoring in an estimated $50 million revenue boost from the Confluent acquisition in the first quarter.
- Stifel reduced from $340 to $290, noting concerns over Confluent integration risks despite positive external factors like geopolitical tensions boosting demand.
New AI Cybersecurity Initiative
IBM continues to innovate with the launch of Autonomous Security, an AI-powered cybersecurity platform. This solution automates threat detection and response, reducing human intervention and enhancing enterprise privacy protections.
Such advancements support IBM’s robust earnings trajectory, driving stock momentum and investor interest in engineering giants.
